3PA-22329-04044
4 vaccinations
1 coded response
25 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 956 / CA
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2021-01-19
Registered in v-safe
-
2021-01-19
Dose 2 — Pfizer-BioNTech
- 2021-01-19
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-04-20
- 2021-07-20
-
2021-10-11
Dose 3 — Pfizer-BioNTech
- 2022-01-19
- 2022-04-18
-
2022-09-30
Dose 4 — Pfizer-BioNTech
- 2022-10-13
- 2022-10-14
- 2022-10-23
- 2022-10-28
- 2022-11-04
-
2022-11-11
Survey response — day 42, dose 4MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Runny nose, congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-12-30
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-10-11 | Pfizer-BioNTech | No |
| 4 | 2022-09-30 | Pfizer-BioNTech | No |
Free text
Release 12 — day 42, dose 4
Symptoms: Runny nose, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release